LSZ L-tartrate Puur
LSZ L-tartrate Puur €3,200.00
Back to products
3-FPM 50 MG Pellets (3-Fluorophenmetrazine)
3-FPM 50 MG Pellets (3-Fluorophenmetrazine) Price range: €21.95 through €399.95
2/3-FEA 40 MG/120MG Pellets - Image 1

2/3-FEA 40 MG/120MG Pellets

Replaced by Newphoria 2/3-FEA Pellets >>

Price range: €17.50 through €930.02

Add to compare
Add to wishlist
SAVE 15%

more 2 products

SAVE 50%

6 for the price of 3

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.

2/3-FEA 40 MG / 120 MG Pellets – Scientific Product Description

General Information

2/3-FEA (2-Fluoroethamphetamine/3-Fluoroethamphetamine)  is a  research compound from the fluoroamphetamine derivative family , with potential stimulant and empathogenic properties. These pellets contain a  precisely dosed combination of 40 mg 2-FEA and 120 mg 3-FEA , optimized for  preclinical studies  of pharmacodynamic interactions.

Applications & Research Areas

Due to its unique dual structure, 2/3-FEA is studied for:

  1. Neurotransmitter research  – Effects on dopamine, norepinephrine, and serotonin release.

  2. Behavioral pharmacology  – Influences on locomotor activity and reward systems in animal models.

  3. Stimulant Effects  – Comparative Studies with Classical Amphetamines.

  4. Receptor affinity studies  – Investigation of selectivity for monoamine transporters.

⚠ Not for human use – For in vitro and controlled animal testing only.

Dosage & Administration

Preclinical Guidelines:

  • Low Active Range:  0.5-2 mg/kg (for subtle effects)

  • Moderate Range:  2-5 mg/kg (clear behavioural effects)

  • High Range:  5-10 mg/kg (for acute toxicity studies only)

Solubility:

  • Freely soluble in  physiological saline  (for injection)

  • Sparingly soluble in  DMSO  (for in vitro work)

Routes of administration:

  • Oral (animal models)

  • Intraperitoneal (for faster absorption)

  • In vitro transporter assays

Safety Aspects & Risks

Acute Risks:

  • Cardiovascular stress  (increased heart rate/blood pressure)

  •  High-dose hyperthermia

  • Serotonin syndrome  when combined with MAO inhibitors

Chronic Risks:

  • Neurotoxicity  (at long-term high doses)

  • Dopaminergic depletion

  • Behavioral sensitization

Laboratory analysis & Quality control

Analytical Specifications:

  • HPLC-MS confirmation  of composition

  • Ratio 1:3 (2-FEA:3-FEA)  with <5% variance

  • No detectable isomeric impurities

  • Microbiological purity:  <100 CFU/g

Stability data:

  • Shelf life:  24 months at 4°C

  • Photosensitivity:  Store in amber packaging

Recommended Research Protocols

  1. Microdialysis Studies

    • Real-time monitoring of extracellular dopamine in nucleus accumbens

  2. Conditioned Place Preference

    • Reward potential evaluation

  3. Thermoregulation Studies

    • Effects on body temperature

  4. Electrophysiology

    • Firing pattern analysis of dopamine neurons

Frequently Asked Questions

Q1: What is the main difference between 2-FEA and 3-FEA?
A: 2-FEA exhibits greater  dopaminergic selectivity , while 3-FEA has stronger  serotonergic effects  .

Q2: How does this combination compare to 3-FMA?
A: The 2/3-FEA combination has a  milder effect profile  with lower neurotoxicity potential.

Q3: Is there a risk of isomer formation?
A: Our analytical data shows that  no undesirable isomers  are formed when stored correctly.

Legal Note:
This product falls under the  Opium Act  in the Netherlands and is  intended solely for lawful scientific research  with the necessary permits.

Storage conditions:

  • Temperature: 2-8°C

  • Protected from moisture and light

  • Store away from food